Ruijian Med Secures $29M for AI-Driven Cell Therapy
Ruijian Medicine raises 210M RMB to advance its AI-driven chemical induction platform and global cell therapy pipelines.
🏷️ Cell Therapy
2 articles about 'Cell Therapy'
Weitao Bio Raises Over $50 Million in Series A Funding
Weitao Bio has completed Series A and A+ rounds of financing, raising a cumulative total of over $50 million. The funds …
1